Across TCGA pan-cancer cohorts, LINC01751 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC01751’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01751 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01751 is over-expressed in tumor.
KIRC and KIRP are the cancer types where LINC01751 tumor–normal differential expression is most reproducible.